Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Financing to close Nov 20

<< Previous

Bullboard Posts

Next >>

Post by james700on Nov 17, 2023 8:35pm

447 Views

Post# 35742198

Financing to close Nov 20

So, it appears that they raised $1.5M. I did contact Theralase and ask why they did not email all the shareholders at the same time as they announced the financing. We probably all would have signed up for the financing, instead of buying existing shares at sub $0.20. The future of TLT is in the interest of all the long term shareholders..500 shareholders times $5,000 is $2.5M. This current stop gap financing will close Monday Nov 20th. Good luck to all longs.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals